Why CVS Health Shares Are Falling Today

CVS Health Corp's (NYSE: CVS) Q1 sales increased 11% Y/Y to $85.28 billion, beating the consensus of $80.95 billion.

The company's pharmacy and consumer wellness segment saw revenue grow 12% to $25.88 billion, as increased prescription volumes and higher prices offset declining revenue from fewer Covid-19 vaccines and tests. 

Prescriptions filled increased by 2.5% on a 30-day equivalent basis, primarily driven by increased utilization and the impact of an elevated cough, cold & flu season, partially offset by a decrease in COVID-19 vaccinations.

Excluding the impact of COVID-19 vaccinations, prescriptions filled increased by 4.5%.

Related: Investors Underestimate Power Of This Pieced Flywheel: Analyst Kicks Off Coverage On CVS Health.

Its health services segment reported revenue of $44.59 billion, up 13% from a year ago.

The insurance business' medical benefit ratio, or spending on claims against premiums earned, was 84.6%, compared with 83.4% a year earlier, reflecting the continued progression towards normalized utilization.

Adjusted EPS was $2.20, beating the consensus of $2.09.

On March 29, CVS Health completed the nearly $8 billion acquisition of Signify Health, adding in-home services to its offerings. 

On May 2, the company closed its $10.6 billion deal for Oak Street Health's 600 primary-care centers.

Outlook: CVS Health has lowered FY23 adjusted EPS to $8.50-$8.70 from prior guidance of $8.70-$8.90 and the consensus of $8.75.

The company also confirmed its full-year 2023 cash flow from the operations guidance range of $12.5 billion to $13.5 billion.

Price Action: CVS shares are down 3.09% at $70.51 on the last check Wednesday.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsLarge CapNewsGuidanceHealth CareMoversGeneralwhy it's moving
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!